Literature DB >> 22370429

Single molecule enzyme-linked immunosorbent assays: theoretical considerations.

Lei Chang1, David M Rissin, David R Fournier, Tomasz Piech, Purvish P Patel, David H Wilson, David C Duffy.   

Abstract

We have developed a highly sensitive immunoassay-called digital ELISA-that is based on the detection of single enzyme-linked immunocomplexes on beads that are sealed in arrays of femtoliter wells. Digital ELISA was designed to be highly efficient in the capturing of target proteins, labeling of these proteins, and their detection in single molecule arrays (SiMoA); in essence, the goal of the assay is to "capture every molecule, detect every molecule". Here we provide the theoretical basis for the design of this assay derived from simple equations based on bimolecular interactions. Using these equations and knowledge of the concentrations of reagents, the times of interactions, and the on- and off-rates of the molecular interactions for each step of the assay, it is possible to predict the number of immunocomplexes that are formed and detected by SiMoA. The unique ability of SiMoA to count single immunocomplexes and determine an average number of enzymes per bead (AEB), makes it possible to directly compare the number of molecules detected experimentally to those predicted by theory. These predictions compare favorably to experimental data generated for a digital ELISA for prostate specific antigen (PSA). The digital ELISA process is efficient across a range of antibody affinities (K(D)~10(-11) -10(-9) M), and antibodies with high on-rates (k(on)>10(5) M(-1) s(-1)) are predicted to perform best. The high efficiency of digital ELISA and sensitivity of SiMoA to enzyme label also makes it possible to reduce the concentration of labeling reagent, reduce backgrounds, and increasing the specificity of the approach. Strategies for dealing with the dissociation of antibody complexes over time that can affect the signals in an assay are also described.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370429      PMCID: PMC3327511          DOI: 10.1016/j.jim.2012.02.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  21 in total

1.  Bioassay of prostate-specific antigen (PSA) using microcantilevers.

Authors:  G Wu; R H Datar; K M Hansen; T Thundat; R J Cote; A Majumdar
Journal:  Nat Biotechnol       Date:  2001-09       Impact factor: 54.908

2.  Cell lysis and protein extraction in a microfluidic device with detection by a fluorogenic enzyme assay.

Authors:  Eric A Schilling; Andrew Evan Kamholz; Paul Yager
Journal:  Anal Chem       Date:  2002-04-15       Impact factor: 6.986

3.  Development and characterization of a series of soluble tetrameric and monomeric streptavidin muteins with differential biotin binding affinities.

Authors:  M H Qureshi; J C Yeung; S C Wu; S L Wong
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

4.  Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system.

Authors:  R Karlsson; A Michaelsson; L Mattsson
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

5.  Photon correlation spectroscopy of human IgG.

Authors:  T Jøssang; J Feder; E Rosenqvist
Journal:  J Protein Chem       Date:  1988-04

6.  Sensitive spectroscopic detection of large and denatured protein aggregates in solution by use of the fluorescent dye Nile red.

Authors:  Marc Sutter; Sabrina Oliveira; Niek N Sanders; Bart Lucas; Arie van Hoek; Mark A Hink; Antonie J W G Visser; Stefaan C De Smedt; Wim E Hennink; Wim Jiskoot
Journal:  J Fluoresc       Date:  2007-02-09       Impact factor: 2.217

7.  Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.

Authors:  David H Wilson; David W Hanlon; Gail K Provuncher; Lei Chang; Linan Song; Purvish P Patel; Evan P Ferrell; Herbert Lepor; Alan W Partin; Dan W Chan; Lori J Sokoll; Carol D Cheli; Robert P Thiel; David R Fournier; David C Duffy
Journal:  Clin Chem       Date:  2011-10-13       Impact factor: 8.327

8.  Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study.

Authors:  Herbert Lepor; Carol D Cheli; Robert P Thiel; Samir S Taneja; Juliana Laze; Dan W Chan; Lori J Sokoll; Leslie Mangold; Alan W Partin
Journal:  BJU Int       Date:  2011-10-12       Impact factor: 5.588

9.  Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen.

Authors:  Janet M Barletta; Daniel C Edelman; Niel T Constantine
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

10.  Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans.

Authors:  Henrik Zetterberg; Erik Mörtberg; Linan Song; Lei Chang; Gail K Provuncher; Purvish P Patel; Evan Ferrell; David R Fournier; Cheuk W Kan; Todd G Campbell; Ray Meyer; Andrew J Rivnak; Brian A Pink; Kaitlin A Minnehan; Tomasz Piech; David M Rissin; David C Duffy; Sten Rubertsson; David H Wilson; Kaj Blennow
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

View more
  39 in total

Review 1.  Emerging technologies to increase ligand binding assay sensitivity.

Authors:  Saloumeh K Fischer; Alison Joyce; Mark Spengler; Tong-Yuan Yang; Yao Zhuang; Marianne Scheel Fjording; Alvydas Mikulskis
Journal:  AAPS J       Date:  2014-10-18       Impact factor: 4.009

Review 2.  Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexing.

Authors:  Johanna Mora; Allison Given Chunyk; Mark Dysinger; Shobha Purushothama; Claude Ricks; Karolina Osterlund; Valerie Theobald
Journal:  AAPS J       Date:  2014-09-06       Impact factor: 4.009

3.  Circulating blood cellular glucose transporters - Surrogate biomarkers for neonatal hypoxic-ischemic encephalopathy assessed by novel scoring systems.

Authors:  Liesbeth V Maggiotto; Monica Sondhi; Bo-Chul Shin; Meena Garg; Sherin U Devaskar
Journal:  Mol Genet Metab       Date:  2019-05-29       Impact factor: 4.797

4.  A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's Perspective.

Authors:  Allison Given Chunyk; Alison Joyce; Saloumeh K Fischer; Mark Dysinger; Alvydas Mikulskis; Andreas Jeromin; Rosemary Lawrence-Henderson; Dana Baker; David Yeung
Journal:  AAPS J       Date:  2017-12-01       Impact factor: 4.009

Review 5.  Single-molecule fluorescence resonance energy transfer in molecular biology.

Authors:  Dibyendu K Sasmal; Laura E Pulido; Shan Kasal; Jun Huang
Journal:  Nanoscale       Date:  2016-12-08       Impact factor: 7.790

Review 6.  Re-Evaluating the Conventional Wisdom about Binding Assays.

Authors:  Brandon D Wilson; H Tom Soh
Journal:  Trends Biochem Sci       Date:  2020-05-10       Impact factor: 13.807

7.  Identification and characterization of small molecule inhibitors of a plant homeodomain finger.

Authors:  Elise K Wagner; Nidhi Nath; Rod Flemming; John B Feltenberger; John M Denu
Journal:  Biochemistry       Date:  2012-10-02       Impact factor: 3.162

8.  Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation.

Authors:  Julia Litvinov; Anna E V Hagström; Yubitza Lopez; Meenu Adhikari; Katerina Kourentzi; Ulrich Strych; Federico A Monzon; William Foster; Philip T Cagle; Richard C Willson
Journal:  Biotechnol Lett       Date:  2014-06-15       Impact factor: 2.461

9.  Oil-isolated hydrogel microstructures for sensitive bioassays on-chip.

Authors:  Rathi L Srinivas; Stephen D Johnson; Patrick S Doyle
Journal:  Anal Chem       Date:  2013-11-22       Impact factor: 6.986

10.  Theoretical limitations of quantification for noncompetitive sandwich immunoassays.

Authors:  Christine F Woolley; Mark A Hayes; Prasun Mahanti; S Douglass Gilman; Tom Taylor
Journal:  Anal Bioanal Chem       Date:  2015-09-05       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.